ClinVar Miner

Submissions for variant NM_000017.4(ACADS):c.988C>T (p.Arg330Cys)

gnomAD frequency: 0.00046  dbSNP: rs140853839
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000185690 SCV000238611 pathogenic not provided 2017-12-08 criteria provided, single submitter clinical testing R330C missense mutations in the ACADS gene have been reported previously in association with short chain acyl-CoA dehydrogenase (SCAD) deficiency (van Maldegem et al., 2006). The variant is found in ACADS panel(s).
Fulgent Genetics, Fulgent Genetics RCV000762888 SCV000893277 likely pathogenic Deficiency of butyryl-CoA dehydrogenase 2021-09-23 criteria provided, single submitter clinical testing
Invitae RCV000762888 SCV000942230 pathogenic Deficiency of butyryl-CoA dehydrogenase 2024-01-04 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 330 of the ACADS protein (p.Arg330Cys). This variant is present in population databases (rs140853839, gnomAD 0.2%). This missense change has been observed in individual(s) with short-chain acyl-coA dehydrogenase (SCAD) deficiency (PMID: 16926354, 18676165; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 203557). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ACADS protein function. For these reasons, this variant has been classified as Pathogenic.
Revvity Omics, Revvity RCV000762888 SCV002023979 likely pathogenic Deficiency of butyryl-CoA dehydrogenase 2020-10-01 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000762888 SCV002033280 likely pathogenic Deficiency of butyryl-CoA dehydrogenase 2021-11-07 criteria provided, single submitter clinical testing
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV002252029 SCV002522862 likely pathogenic See cases 2021-10-15 criteria provided, single submitter clinical testing ACMG classification criteria: PS4, PM2, PM3, PP3
Counsyl RCV000762888 SCV001132320 likely pathogenic Deficiency of butyryl-CoA dehydrogenase 2016-12-21 no assertion criteria provided clinical testing
Neonatal Disease Screening Center, Medical Genetics Center, Huaihua City Maternal and Child Health Care Hospital RCV000762888 SCV004800871 likely pathogenic Deficiency of butyryl-CoA dehydrogenase no assertion criteria provided clinical testing PM2_P+PM3_S+PM5+PP3+PP4

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.